CAMBRIDGE, MA / ACCESS Newswire / November 3, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has ...
Cardiovascular disease continues to be the leading cause of death worldwide. But advances in heart-failure therapeutics have ...
A UC Berkeley-led research team discovered a new method of administering treatment for heart diseases, with the aid of a chip ...
The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...
The official opening will be headlined by Dr Nomalungelo Gina, Deputy Minister of Science, Technology and Innovation, who ...
Opinion
A Medical Breakthrough Saved Millions of Lives During COVID. Why Are We Turning Our Backs on It Now?
The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in federal funding to develop new mRNA vaccines against potentially ...
The decades-long quest to harness the power of messenger RNA to enhance cancer treatment has focused primarily on its value ...
An update from Veritas In Silico Inc. ( ($JP:130A) ) is now available. Veritas In Silico Inc. and Dexerials Corporation have announced a joint ...
By activating an immune signaling pathway inside cancer cells, MIT researchers found a way to force tumors to produce a molecule that leads to their own destruction.
ATLANTA — Moderna’s respiratory syncytial virus vaccine is safe and effective for adults who have received a solid organ ...
MRNA research enabled the remarkably fast production of COVID-19 vaccine candidates in the pandemic. But more broadly, the ...
South Africa's biggest pharmaceutical producer Aspen Pharmacare said on Friday it had reached a 25 million euro ($29.2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback